Personalized immune cells fight advanced cancers in new trial
NCT ID NCT07260058
Summary
This study is testing a personalized immune cell therapy for people with advanced lung, liver, colorectal, or breast cancer. Doctors take a patient's own blood cells, grow and activate immune cells in a lab, and then infuse them back into the patient to help the body's immune system fight the cancer. The main goals are to see if the treatment is safe and if it can shrink tumors or stop them from growing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.